These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Riluzole--what is its impact in our treatment and understanding of amyotrophic lateral sclerosis? Mitsumoto H Ann Pharmacother; 1997 Jun; 31(6):779-81. PubMed ID: 9184724 [TBL] [Abstract][Full Text] [Related]
12. Clinical trials of riluzole in patients with ALS. ALS/Riluzole Study Group-II. Miller RG; Bouchard JP; Duquette P; Eisen A; Gelinas D; Harati Y; Munsat TL; Powe L; Rothstein J; Salzman P; Sufit RL Neurology; 1996 Oct; 47(4 Suppl 2):S86-90; discussion S90-2. PubMed ID: 8858057 [TBL] [Abstract][Full Text] [Related]
13. The Riluzole Early Access Programme: descriptive analysis of 844 patients in France. ALS/Riluzole Study Group III. Meininger V; Dib M; Aubin F; Jourdain G; Zeisser P J Neurol; 1997 May; 244 Suppl 2():S22-5. PubMed ID: 9178167 [TBL] [Abstract][Full Text] [Related]
14. Riluzole: a new agent for amyotrophic lateral sclerosis. Wagner ML; Landis BE Ann Pharmacother; 1997 Jun; 31(6):738-44. PubMed ID: 9184716 [TBL] [Abstract][Full Text] [Related]